Clinical Trial Update: Immunohistochemical Algorithm for the Diagnosis and Classification of Hepatocellular Carcinomas With TERT, TP53 and CTNNB1 Mutation [NA]

View source ↗

Summary

A clinical trial is evaluating an immunohistochemical algorithm for diagnosing and classifying hepatocellular carcinoma with mutations in TERT, TP53, and CTNNB1…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna | Conditions: Hepatic Cancer, Hepatic Resection | NA | Status: RECRUITING